SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-22-000364
Filing Date
2022-11-03
Accepted
2022-11-03 12:02:10
Documents
29
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl1103form10q.htm   iXBRL 10-Q 226665
2 EXHIBIT 31.1 cncl1103form10qexh31_1.htm EX-31.1 8076
3 EXHIBIT 31.2 cncl1103form10qexh31_2.htm EX-31.2 8090
4 EXHIBIT 32.1 cncl1103form10qexh32_1.htm EX-32.1 3873
  Complete submission text file 0001554795-22-000364.txt   1074446

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cncl-20220930.xsd EX-101.SCH 8497
6 XBRL CALCULATION FILE cncl-20220930_cal.xml EX-101.CAL 17894
7 XBRL DEFINITION FILE cncl-20220930_def.xml EX-101.DEF 10311
8 XBRL LABEL FILE cncl-20220930_lab.xml EX-101.LAB 92771
9 XBRL PRESENTATION FILE cncl-20220930_pre.xml EX-101.PRE 66202
23 EXTRACTED XBRL INSTANCE DOCUMENT cncl1103form10q_htm.xml XML 68188
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 221356979
SIC: 6770 Blank Checks